AIC
GHDX

Aurora Investment Counsel’s Genomic Health, Inc. GHDX Stock Holding History

Aurora Investment Counsel’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20,916
Closed -$1.35M – 135
2018
Q4 		$1.35M Sell
20,916
-20,337
-49% -$1.43M 0.73% 80
2018
Q3 		$2.9M Sell
41,253
-12,871
-24% -$753K 1.38% 6
2018
Q2 		$2.73M Sell
54,124
-1,931
-3% -$76.6K 1.33% 7
2018
Q1 		$1.75M Buy
56,055
+1,102
+2% +$36.6K 0.88% 62
2017
Q4 		$1.88M Buy
+54,953
New +$1.75M 0.94% 60

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aurora Investment Counsel's GHDX Position: Q1 2019 in Review

Aurora Investment Counsel sold out of Genomic Health, Inc. (GHDX) in Q1 2019, closing a stake of 20,916 shares — an estimated $1.35M sold.

Aurora Investment Counsel first reported a position in GHDX in Q4 2017 and held it in 5 quarters. The position peaked at $2.9M in Q3 2018. 267 funds tracked by Wall St. Rank hold GHDX as of Q1 2019.

  • Aurora Investment Counsel reported no remaining Genomic Health, Inc. position as of Q1 2019 after selling out during the quarter.
  • Aurora Investment Counsel sold 20,916 Genomic Health, Inc. shares in Q1 2019, an estimated $1.35M.
  • Aurora Investment Counsel first reported a position in Genomic Health, Inc. in Q4 2017 and held it in 5 quarters.
  • Aurora Investment Counsel's Genomic Health, Inc. position peaked at $2.9M in Q3 2018.
  • 267 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2019.

Based on Aurora Investment Counsel's 13F filing for Q1 2019, filed 16 Apr 2019.